Company Snapshot of RapidAI
SINCE 2011 For 20+ years, most believed we had only a few hours after a stroke to provide treatment—but the RapidAI founders were never satisfied with that thinking. They theorized that stroke evolution was highly variable, the conventional short treatment windows could be upended, and far more people with cerebrovascular disorders could be saved. They recognized that technology was the limiting factor even after an early NIH-funded, multicenter trial showed…